Australia's largest stock trading and investment forum Australia's #1 stock forum

RSH

Click for more information

6.67%

2.8¢ respiri limited

Ann: Half Yearly Report and Accounts, page-22

First 22 Last

Share
Profile

Follow
AlCp

26,832 Posts.

1738

22/02/22

10:37

Post #: 59725637
Share

Originally posted by Richney ↑

This post perfectly sums up your complete lack of knowledge and understanding of the diagnosis and management of asthma and other chronic respiratory disease. The fact that you compare an asthma attack to a panic attack is laughable and shows how little you understand about asthma.

You say that monitoring wheeze means nothing…guess what a doctor does when my son goes in for his 12 month asthma review, they measure and assess his wheezing! And guess what’s one of the first tests a doctor does when diagnosing asthma….you guessed it, they listen for wheezing. This is because wheezing is a primary symptom of a diagnosed asthmatic and a very important indicator as to state and level of construction of a patients airways (which of left unchecked can exacerbate into a full blow asthma attack).

So I guess you can say that assessing and measuring wheeze as the primary symptom of asthma (and other chronic respiratory diseases) I diagnosed asthmatics is incredibly important…so important in fact that it can save lives!

Once again I have had to correct your ever increasing number of mistakes and your complete lack of knowledge. This is important for everyone to see as your posts are both misguided and at worst dangerous. So you can keep banging on about how wheeze means nothing and it does not mean you have asthma or an asthma attack. This may be the case if you are not a diagnosed asthmatic, just like coughing doesn’t mean you have pneumonia, cancer, Etc unless you are diagnosed with cancer or pneumonia. Symptoms are indicators of that state of a patients condition who has been diagnosed with that condition so they can actively manage their treatment and medication usage before they end up in an emergency room or dead.

RSH’s technology provides an objective monitoring and management system that gives data on the state of an asthmatic primary symptom in real-time via a measurement of the % of wheeze in a number of breath cycles (inhalation & exhalation) over a short time period (20-30secs). The higher the % reading the higher the wheezing which means the patient airways are constricting. This constricting of the airways, of left unchecked and not addressed with medication can manifest into a catastrophic constriction resulting in an attack or major exacerbation. This does not happen in a few minutes and can happen over a number of hours or days. This is the critical importance of a having a monitoring and management tool like wheezo to be able to regularly measure a patients breathing and implement treatment BEFORE the wheezing and airway constriction is beyond the point of treatment and only can be dealt with in the ER.

Wheezo allows proactive management of asthma symptoms and promotes preventative healthcare….it’s too late once you are in the ER because by then you already know you are having an attack (which could have been hours or days after the diagnosed patient started wheezing).

So I reinforce again, monitoring and managing wheeze in a diagnosed asthmatic is incredibly important, so important in fact that doctors/ specialist do it and it is the primary focus of an asthmatics asthma plan….”is the patient wheezing/measure the patients wheeze”.

Finally, RSH’s other product they have complements Wheezp which is the daytime monitoring and management platform because it is primarily used as a nighttime/overnight system to monitor nocturnal wheeze. Why is this important, because over 75% of all deaths from asthma occur at night! There is currently no other technology in the market that can monitor wheezing overnight in the home and the RSH’s system will be able to do this. So the 2 products that RSH has in its portfolio when combined provide a complete end-to-end objective real-time monitoring System that measures the primary symptom of diagnosed asthmatics, wheezing and allows patients and carers the ability to implement proactive treatment and mediation application for more preventative healthcare and better health outcomes.

SpIrometry tests lung function and is used primarily for diagnosis of chronic respiratory disease and whilst there is portable Spirometry option, it is very rarely used in ongoing monitoring and management and rarely used by doctors in asthma reviews (they use stethoscope and Spirometry too expensive and time consuming for ongoing monitoring and management).

Measuring wheeze day and night in a diagnosed asthmatic is incredibly important as it is a excellent indicator of airway constriction and severity of symptom of a number of hours or days. If measured objectively and regularly it can keep asthmatics out of hospital and alive. It’s the first thing doctors do so it must be important!

Please do not listen to Alcrap when he says wheezing doesn’t mean you are having a asthma attack or even asthma as in a a diagnosed asthmatic it is the primary symptom and when measured objectively in real-time using Wheezo, it will indicator whether a patients airway is constricting (the higher -% wheeze the more dangerous) or not. He is completely wrong.

Expand

Wheezing is very common in children especially toddlers and it doesn't mean they have Asthma. That's why toddlers don't get diagnosis for Asthma and what happen when your son visit the doctor and he isn't wheezing????? If it's so "important" why isn't this successful in Australia despite the millions RSH spent on advertising and marketing resulting in 1.2K unit sold but doesn't correlate to the subscription sale.

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/coughing-and-wheezing-in-children

Last edited by AlCp: 22/02/22

RSH Price at posting: 4.7¢ Sentiment: Hold Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

There are more pages in this discussion • 15 more messages in this thread...

First 22 Last

Add RSH (ASX) to my watchlist

(20min delay)
Last 2.8¢		Change -0.002(6.67%)		Mkt cap ! $32.10M

Open	High	Low	Value	Volume
2.9¢	3.0¢	2.8¢	$6.177K	219.7K

Buyers (Bids)

No.	Vol.	Price($)
1	486755	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	121551	1

View Market Depth

No.	Vol.	Price($)
1	486755	0.026
1	400000	0.025
1	632000	0.024
1	130000	0.022
4	463245	0.021

Price($)	Vol.	No.
0.030	121551	1
0.031	224116	2
0.032	615000	5
0.034	400000	1
0.035	199456	1

Last trade - 13.30pm 17/07/2024 (20 minute delay)

RSH (ASX) Chart